A forthcoming book by Dr. David Agus is rife with instances of plagiarism. After being contacted by The Times, Agus and Simon & Schuster have halted publication.
PME October 2021 - Time for pharma to ditch its cautious approach to creativity in comms, Alzheimer’s disease and beyond, Amarin is rethinking cardiovascular risk
PME September 2021 - Celebrating a return to the live Communiqué Awards, Creating behaviour change through teamwork, Antimicrobial resistance: the silent epidemic
Pharmaceutical companies ramp up efforts to get the brain’s immune cells to help treat Alzheimer’s disease and other conditions, but not everyone agrees the approach will be effective.